Why low-dose aspirin persists in recurrent pregnancy loss without APS: cognitive bias and system design
Low-dose aspirin (LDA) is widely prescribed for recurrent pregnancy loss (RPL) even when antiphospholipid syndrome (APS) is absent, despite high-level evidence showing no improvement in live-birth rate in such cases. In Japan and elsewhere, this empirical use persists across fertility and obstetric...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2026-02-01
|
| Col·lecció: | AJOG Global Reports |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2666577825001637 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
